Scientific Opinion on application (EFSA-GMO-UK-2007-48) for the placing on the market of insect resistant and herbicide tolerant genetically modified maize MIR604 x GA21 for food and feed uses, import and processing under Regulation (EC) No 1829/2003 from Syngenta Seeds

Tabs

Article
Panel on Genetically Modified Organisms
Acknowledgements

The GMO Panel wishes to thank the members of the Working Groups on Molecular Characterisation, Food/Feed and Environment for the preparation of this opinion and EFSA’s staff members Yann Devos, Zoltán Divéki and Ellen Van Haver for the support provided to this EFSA scientific output.

EFSA Journal
EFSA Journal 2010; 8(5):1611 [30 pp.].
doi
10.2903/j.efsa.2010.1611
Panel members at the time of adoption
Hans Christer Andersson, Salvatore Arpaia, Detlef Bartsch, Josep Casacuberta, Howard Davies, Patrick du Jardin, Gerhard Flachowsky, Lieve Herman, Huw Jones, Sirpa Kärenlampi, Jozsef Kiss, Gijs Kleter, Harry Kuiper, Antoine Messéan, Kaare Magne Nielsen, Joe Perry, Annette Poeting, Jeremy Sweet, Christoph Tebbe, Atte Johannes von Wright, and Jean-Michel Wal.
Contact
Type
Opinion of the Scientific Committee/Scientific Panel
On request from
Competent Authority of the United Kingdom for application (EFSA-GMO-UK-2007-48) submitted by Syngenta Seeds
Question Number
EFSA-Q-2007-196
Adopted
29 April 2010
Published
18 May 2010
Affiliation
European Food Safety Authority (EFSA), Parma, Italy
Note
Abstract

This scientific opinion reports on an evaluation of a risk assessment for placing on the market the genetically modified insect resistant and herbicide tolerant maize MIR604 x GA21 for food and feed uses, import and processing. Conventional crossing methods were used in the production of maize MIR604 x GA21 from lines of the respective single maize events. The structure of the inserts in the single maize events, as well as the phenotypes were both retained in the stacked maize events. The expression levels of the mCry3A, PMI and mEPSPS proteins in maize MIR604 x GA21 were demonstrated to be comparable with those of the respective single maize events. The comparative analysis of compositional, phenotypic and agronomic characteristics indicated equivalence of maize MIR604 x GA21 with its conventional counterpart, except for the newly expressed proteins which provided resistance to certain coleopteran target pests and tolerance to glyphosate-based herbicides. The safety assessment identified no concerns regarding potential toxicity and allergenicity of maize MIR604 x GA21. Considering the intended uses of maize MIR604 x GA21, which excludes cultivation within the European Union, no scientific assessment of potential environmental effects associated with cultivation of maize MIR604 x GA21 was required. In case of accidental release of viable maize MIR604 x GA21 grains into the environment during transportation and processing, there are no indications of increased likelihood of establishment or survival of feral maize plants, except in the presence of glyphosate-based herbicides. It is highly unlikely that the recombinant DNA will transfer and establish in the genome of bacteria in the environment or human and animal digestive tracts. In conclusion, the EFSA GMO Panel considers that information available for maize MIR604 x GA21 addresses the scientific comments raised by Member States, and that the maize MIR604 x GA21, as assessed in this application, is as safe as its conventional counterpart and other appropriate comparators with respect to potential effects on human and animal health and the environment in the context of its intended uses. The EFSA GMO Panel concludes that maize MIR604 x GA21 is unlikely to have an adverse effect on human and animal health and environment in the context of its intended uses.

Keywords
GMO, maize (Zea mays), MIR604 x GA21, insect resistance, herbicide tolerance, stacked events, risk assessment, food and feed safety, environmental safety, food and feed uses, import, processing, Regulation (EC) No 1829/2003
Print on demand
Number of Pages
30